hysteroscopic surgery
Conditions
Interventions
Experimental group:Ciprofol sedation
Sponsors
The First Hospital of Lanzhou University
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: (1) patients to undergo hysteroscopic surgery;(2) American Association of Anesthesiologists (ASA) grade I ~ II;(3) 18-49 years old;(4) body mass index, BMI18~30kg/m2;(5) patients agreed to participate in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Serious heart, liver, kidney, lung and other important organ diseases;2. Allergic to benzodiazepines and long-term use of benzodiazepines;3. History of drug or alcohol abuse;4. Previous history of anesthetic allergy;5. Participate in other drug trials within 3 months;6. The modified Mallampati grade is ? 7. Mental disorders or communication difficulties;8. Dyspnea or recent respiratory infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjects' heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, pulse oxygen saturation during the trial process;Anesthesia onset time,Operating time,Awake time;The occurrence of various adverse events during the trial process of the subjects(Adverse reactions such as injection pain, hypoxemia, hypotension, bradycardia, intraoperative body movement, postoperative nausea and vomiting, and the occurrence of drug supplementation times greater than 5 times); | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgeon, anesthesiologist and patient satisfaction scores(VAS); | — |
Countries
China
Contacts
Public ContactLeng Yufang
The First Hospital of Lanzhou University
Outcome results
None listed